NCLT approves clinic demerger into Narayana Hrudayalaya
Narayana Hrudayalaya received NCLT approval to transfer 10 clinics from wholly owned subsidiary NH Integrated Care without issuing new shares. The stock closed 3.3% higher at ₹1,932 on 4 November 2026, according to OI Charts data.
pre-market1 source ↓machine-written, see hownot a recommendation
- NH close
- ₹1,932
- On the day
- +3.26%
- 52-week high
- ₹2,093
- 52-week low
- ₹1,589
The Bengaluru Bench of the National Company Law Tribunal sanctioned the Scheme of Arrangement between NH Integrated Care Private Limited and Narayana Hrudayalaya Limited on 30 October 2026. The order, issued in C.P.(CAA) No. 14/BB/2026, was uploaded on exchange systems on 4 November 2026 under Regulation 30 of the SEBI Listing Regulations. NCLT scheme approval moves the proposed transfer of the Clinical Services undertaking into the next implementation stage. 🏥
The undertaking covers 10 clinics on a going-concern basis: nine in Bengaluru and one in Hosur. Since NH Integrated Care is a wholly owned subsidiary, the transaction does not involve issuing new shares as consideration. The company’s share capital and shareholding pattern therefore remain unchanged, removing an immediate dilution concern for existing shareholders. The appointed date under the scheme is 1 April 2025.
For the healthcare business, the arrangement brings the clinics under the listed parent’s operating structure and consolidates its clinical-services footprint in southern India. The available disclosure does not provide a transaction value, revenue contribution, profitability detail or implementation timeline beyond the approval process. The scheme becomes effective only after the certified copy of the order and the required procedural steps are completed. The next exchange filing confirming effectiveness and operational transfer is therefore the key event to monitor. ⚖️
The stock reacted positively around the disclosure date. OI Charts data for 4 November 2026 showed a close of ₹1,932, up 3.3% on the day, with volume of 214,340 shares. The move followed a 12.1% rise over five sessions and a 10.9% gain over 20 sessions. The stock remained below its 52-week high of ₹2,093 recorded on 17 November 2025 and above its 52-week low of ₹1,589 recorded on 2 April 2026. 📈
The market focus now shifts to confirmation of the scheme’s effective date and the operational transfer of the clinics. Subsequent disclosures on clinic revenue, capacity, utilisation and earnings contribution will determine how the healthcare sector assesses the strategic value of the demerger. The approval itself does not change the company’s share count or ownership structure.
Source: Kalkine India, 04 Nov 2026
Not investment advice. For informational purposes only.